VivoSeq
Other

Antidepressants

0

Pipeline Programs↗

4

Active Trials↗

4

Companies Involved↗

Antidepressants is an early-stage landscape with 0 programs across 4 companies. The most active players are Eli Lilly, Pfizer, GSK.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Eli Lilly logo

Eli Lilly

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalTibotec Pharmaceuticals, Ireland logo

Tibotec Pharmaceuticals, Ireland

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

36

clinical trials

Completed20 · 56%
Unknown status7 · 19%
Terminated3 · 8%
Not yet recruiting3 · 8%
Withdrawn2 · 6%
Recruiting1 · 3%

Clinical Trials

Trial Activity

36 trials

Personalized Indications for CBT and Antidepressants in Treating Depression
Recruiting·NNova Scotia Health Authority·Phase 4·NCT02752542·80 enrolled
Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants
Not yet recruiting·GGermans Trias i Pujol Hospital·N/A·NCT06337539·50 enrolled
Discontination of Antidepressants in Remitted Depression
Not yet recruiting·UUniversita di Verona·Phase 4·NCT07393919·150 enrolled
Deprescription of Antidepressants in Primary Care (DAPriCare)
Not yet recruiting·UUniversity of Huelva·Phase 1·NCT06796946·325 enrolled
OxSYPan: Oxford Study With Young People on Antidepressants
Completed·UUniversity of Oxford·N/A·NCT03436173·32 enrolled
Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
Completed·SSykehuset Innlandet HF·Phase 4·NCT00433121·24 enrolled
Antiglucocorticoid Augmentation of antiDepressants in Depression
Completed·—·Phase 3·NCT01375920·190 enrolled
Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin
Completed·TThomas Jefferson University·Phase 4·NCT00449683·23 enrolled
Strategic Use of New Generation Antidepressants for Depression
Completed·KKyoto University·Phase 4·NCT01109693·2,011 enrolled
Switching to Duloxetine From Other Antidepressants
Completed·Eli Lilly logoEli Lilly·Phase 4·NCT00191932·360 enrolled
Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
Completed·Pfizer logoPfizer·Phase 4·NCT00474708·1,151 enrolled
A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression
Completed·KKunming Medical University·N/A·NCT00703742·200 enrolled
Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer
Completed·UUNC Lineberger Comprehensive Cancer Center·Phase 1·NCT01725048·21 enrolled
Nicotinic Receptor Augmentation of SSRI Antidepressants
Completed·YYale University·Phase 2·NCT00319319·60 enrolled
Are Two Antidepressants a Good Initial Treatment for Depression?
Completed·NNew York State Psychiatric Institute·Phase 4·NCT00296712·55 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)